openPR Logo
Press release

Oligonucleotide-based Therapies Market Supports Growing Demand for Bioproduction

10-28-2021 03:25 PM CET | Health & Medicine

Press release from: The Insight Partners

Oligonucleotide-based Therapies Market Supports Growing

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Oligonucleotides are short chain RNA or DNA typically made by using automated synthesizers. Oligonucleotides therapy is different from conventional medicine since it can inhibit the expression of specific genes and their development takes place with the raw chemical modified artificial nucleus acids. This lead to development of brand new oligonucleotides targeting certain genes and treating chronic diseases. They are broadly used in applications such as infectious diseases, oncology, kidney diseases, and cardiovascular diseases.

The "Global Oligonucleotide-Based Therapies Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the oligonucleotide-based therapies market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading oligonucleotide-based therapies market players and offers key trends and opportunities in the market.

To get sample Copy of the report, along with the TOC, Statistics @ https://www.theinsightpartners.com/sample/TIPRE00022877/?utm_source=OpenPR&utm_medium=10291

Here we have listed the top Oligonucleotide-based Therapies Market companies

1. PCI Biotech
2. SomaGenics
3. InteRNA Technologies
4. Frontiers
5. miRagen Therapeutics, Inc.
6. Ionis Pharmaceuticals, Inc.
7. Aligos Therapeutics
8. Gilead Sciences, Inc.
9. Biogen Inc.
10. Regulus Therapeutics Inc.

Highlights the following key factors:

1) Business description-A detailed description of the company’s operations and business divisions.

2) Corporate strategy – Analyst’s summarization of the company’s business strategy.

3) SWOT Analysis-A detailed analysis of the company’s strengths, weakness, opportunities, and threats.

4) Company history – Progression of key events associated with the company.

5) Major products and services-A list of major products, services, and brands of the company.

6) Key competitors – A list of key competitors to the company.

7) Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

8) Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 7 years history.

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Oligonucleotide-based Therapies Market which would mention How the Covid-19 is Affecting the Oligonucleotide-based Therapies Market Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Oligonucleotide-based Therapies Market Players to fight Covid-19 Impact.

ASSESING THE COVID-19 IMPACT on Oligonucleotide-based Therapies Market ? Visit Here for PDF Copy >>https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00022877/?utm_source=OpenPR&utm_medium=10291

Segmentation

Based on type, the global oligonucleotide-based therapies market is segmented into antisense, ribozymes, aptamers, miRNA, CpG/Immunostimulatory and RNAi.
On the basis of application, the market is bifurcated into infectious diseases, oncology, neurodegenerative disorders, cardiovascular diseases, kidney diseases and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Oligonucleotide-based Therapies Market based on product and application. It also provides market size and forecast till 2027 for overall Oligonucleotide-based Therapies Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oligonucleotide-based Therapies Market - By Type
1.3.2 Oligonucleotide-based Therapies Market - By Application
1.3.3 Oligonucleotide-based Therapies Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. OLIGONUCLEOTIDE-BASED THERAPIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. OLIGONUCLEOTIDE-BASED THERAPIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/sample/TIPRE00022877/?utm_source=OpenPR&utm_medium=10291

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oligonucleotide-based Therapies Market Supports Growing Demand for Bioproduction here

News-ID: 2446619 • Views:

More Releases from The Insight Partners

Plant Growth Regulators Market Growth: Trends, Innovations, and Agricultural Impact
Plant Growth Regulators Market Growth: Trends, Innovations, and Agricultural Imp …
The Plant Growth Regulators Market is very strong and continuous, as agriculture increasingly shifts toward productivity and sustainability. Overall demand has been growing in both conventional and organic farming as yields, quality, and resilience continue to improve amidst climate and resource pressures. Download PDF: -https://www.theinsightpartners.com/sample/TIPRE00005154?utm_source=Openpr&utm_medium=10413 Growth regulators are increasingly used in cereals, fruits, vegetables, and specialty crops to optimize flowering, rooting, fruit setting, and stress tolerance, which supports more efficient use of
Refrigeration Coolers Market Set for Strong Growth Driven by Sustainability, Smart Technologies, and Expanding Cold Chain Infrastructure
Refrigeration Coolers Market Set for Strong Growth Driven by Sustainability, Sma …
New York, US - November 26, 2025 - The global Refrigeration Coolers Market is entering a transformative growth phase as industries worldwide embrace advanced cooling technologies to support food preservation, pharmaceutical storage, and energy-efficient commercial refrigeration. The market continues to evolve rapidly, shaped by sustainability initiatives, the rise of cold chain logistics, and the integration of smart, connected cooling systems across a wide range of applications. Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00039596/?utm_source=OpenPR&utm_medium=10759 The
Top Space-based RF and Microwave Technology Companies Analysis By 2031
The Space-based RF and Microwave Technology Market is expected to register a CAGR of 8.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00024426?utm_source=OpenPR&utm_medium=10379 The List of Companies • ASELSAN A.S • Airbus S.A.S. • Cobham Limited • General Dynamics Mission Systems, Inc. • Honeywell International Inc. • HUBER+SUHNER • Kongsberg • L3Harris Technologies, Inc. • Leonardo S.p.A. By Platform • Space-Based Platform • Ground-Based Platform By Component • Transmitter/Receiver Module • Amplifier • RF Switches • RF Cables • Others By Application • Communication • Earth Observation • Navigation/GPS • Others Contact US Contact Person : Ankit
Needle-Free Drug Delivery Devices Market is anticipated to register a CAGR of 8.7% during 2025-2031
Needle-Free Drug Delivery Devices Market is anticipated to register a CAGR of 8. …
The Global Needle-Free Drug Delivery Devices Market is experiencing robust growth driven by increasing demand for painless, convenient, and safer drug administration options. Today's patients and healthcare providers are embracing needle-free technology as an effective alternative to conventional injections, offering reduced pain and lower risk of infections. This surge is backed by technological advancements and growing incidences of chronic diseases requiring frequent drug delivery. Check valuable insights in the Needle-Free Drug

All 5 Releases


More Releases for Therapies

GM1 Gangliosidosis Market: Epidemiology, Therapies, Companies, DelveInsight | Pa …
GM1 Gangliosidosis therapies, such as PBGM01, and others, are expected to boost the GM1 Gangliosidosis Market in the upcoming years. DelveInsight has launched a new report on "GM1 Gangliosidosis - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the GM1 Gangliosidosis, historical and forecasted epidemiology as well as the GM1 Gangliosidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover
Facioscapulohumeral Muscular Dystrophy Pipeline Assessment 2024: Therapies, Clin …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Facioscapulohumeral Muscular Dystrophy pipeline constitutes 10+ key companies continuously working towards developing 10+ Facioscapulohumeral Muscular Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Facioscapulohumeral Muscular Dystrophy Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Facioscapulohumeral Muscular
Intratumoral Cancer Therapies Market Report 2024 - Intratumoral Cancer Therapies …
"The Business Research Company recently released a comprehensive report on the Global Intratumoral Cancer Therapies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The intratumoral cancer therapies
Innovative Therapies in Alcohol Rehabilitation
Alcohol rehabilitation has evolved significantly over the years, with innovative therapies emerging as crucial elements in the journey to recovery. These groundbreaking approaches go beyond traditional methods, providing individuals struggling with alcohol addiction with a diverse set of tools to achieve and maintain sobriety. In this article, we delve into innovative therapies, exploring their effectiveness and impact on alcohol rehabilitation if you'd like to know more about alcohol rehab in
B-cell Maturation Antigen (BCMA) Targeted Therapies Market New Development of No …
A global prevalence of over one million cases. B-cell maturation antigen (BCMA), is a cell surface protein that is expressed on the malignant plasma cells. This cell surface protein has emerged as a very selective antigen targeted therapy for the treatment of multiple myeloma. BCMA targeted therapies actively involve three major types of immunotherapies on the basis of product class namely, chimeric antigen receptor T-cells (CAR T Cells), bispecific antibodies,
Viral Vector Contract Manufacturing Market Outlook 2021- Gene Therapies, Cell Th …
The latest report released on Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines Market analyses areas where there is still room for improvement. Irrespective of industry, organization size or geographic location, the Outlook for Viral Vector Contract Manufacturing - Gene Therapies, Cell Therapies, and COVID-19 Vaccines Market study suggests that advanced technologies are playing a bigger role than ever before. The assessment provides trend,